Metabolomics for Informing Adverse Outcome Pathways: Androgen Receptor Activation and the Pharmaceutical Spironolactone
Metabolite Input Files for Determining Biochemical Pathways Impacted by Spironolactone Exposures of Fathead Minnows (Pimephales promelas) Using the Mummichog Software package.
This dataset is associated with the following publication:
Davis, J., D. Skelton, D. Ekman, C. LaLone, G. Ankley, G. Ankley, J. Cavallin, D. Villeneuve, and T. Collette. Metabolomics for Informing Adverse Outcome Pathways: Androgen Receptor Activation and the Pharmaceutical Spironolactone. AQUATIC TOXICOLOGY. Elsevier Science Ltd, New York, NY, USA, 184(0): 103-115, (2017).
Complete Metadata
| accessLevel | public |
|---|---|
| bureauCode |
[
"020:00"
]
|
| contactPoint |
{
"fn": "Drew Ekman",
"hasEmail": "mailto:ekman.drew@epa.gov"
}
|
| describedBy | https://pasteur.epa.gov/uploads/10.23719/1378557/documents/Data%20Dictionary%20for%20Davis%20et%20al.%202017_Input%20File.docx |
| describedByType | application/vnd.openxmlformats-officedocument.wordprocessingml.document |
| description | Metabolite Input Files for Determining Biochemical Pathways Impacted by Spironolactone Exposures of Fathead Minnows (Pimephales promelas) Using the Mummichog Software package. This dataset is associated with the following publication: Davis, J., D. Skelton, D. Ekman, C. LaLone, G. Ankley, G. Ankley, J. Cavallin, D. Villeneuve, and T. Collette. Metabolomics for Informing Adverse Outcome Pathways: Androgen Receptor Activation and the Pharmaceutical Spironolactone. AQUATIC TOXICOLOGY. Elsevier Science Ltd, New York, NY, USA, 184(0): 103-115, (2017). |
| distribution |
[
{
"title": "Davis et al. 2017_Input Files.xlsx",
"mediaType": "application/vnd.openxmlformats-officedocument.spreadsheetml.sheet",
"downloadURL": "https://pasteur.epa.gov/uploads/10.23719/1378557/Davis%20et%20al.%202017_Input%20Files.xlsx"
}
]
|
| identifier | https://doi.org/10.23719/1378557 |
| keyword |
[
"AOPs",
"Mummichog",
"mass spectrometry",
"metabolomics",
"spironolactone"
]
|
| license | https://pasteur.epa.gov/license/sciencehub-license.html |
| modified | 2017-08-14 |
| programCode |
[
"020:095"
]
|
| publisher |
{
"name": "U.S. EPA Office of Research and Development (ORD)",
"subOrganizationOf": {
"name": "U.S. Environmental Protection Agency",
"subOrganizationOf": {
"name": "U.S. Government"
}
}
}
|
| references |
[
"https://doi.org/10.1016/j.aquatox.2017.01.001"
]
|
| rights |
null
|
| title | Metabolomics for Informing Adverse Outcome Pathways: Androgen Receptor Activation and the Pharmaceutical Spironolactone |
